AURX
Nuo Therapeutics, Inc.
Key Financials
Gross Profit
$2.2M
↑ 108.8%
Net Income
$-2512216
↓ 8.1%
Revenue
$721045
↑ 52.6%
EPS (Diluted)
$-0.03
↓ 111.1%
Operating Income
$-2516649
↓ 2.4%
Total Liabilities
$2.8M
↑ 314.7%
Total Assets
$1.8M
↑ 55.2%
Shareholders' Equity
$-956559.00
↓ 286.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 3/30/2026 | View on SEC |
| SCHEDULE 13G/A | 2/12/2026 | View on SEC |
| 4 | 1/26/2026 | View on SEC |
| SCHEDULE 13D/A | 1/26/2026 | View on SEC |
| 8-K | 1/26/2026 | View on SEC |
| 4 | 1/5/2026 | View on SEC |
| 4 | 12/22/2025 | View on SEC |
| 8-K | 12/17/2025 | View on SEC |
| 4/A | 12/11/2025 | View on SEC |
| 4 | 12/11/2025 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | AURX |
| Company Name | Nuo Therapeutics, Inc. |
| CIK | 1091596 |
| Sector | Surgical & Medical Instruments & Apparatus |
| Industry | Non-accelerated filer Smaller reporting company |
| Exchange | OTC |
| SIC Code | 3841 |
| SIC Description | Surgical & Medical Instruments & Apparatus |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 832-236-9060 |